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A series of recent studies report novel roles for Pak1, a key member of the highly
conserved family of serine-threonine protein kinases regulated by Ras-related small
G-proteins, Cdc42/Rac1, in cardiac physiology and cardioprotection. Previous studies
had identified Pak1 in the regulation of hypertrophic remodeling that could potentially
lead to heart failure. This article provides a review of more recent findings on the
roles of Pak1 in cardiac Ca2+ homeostasis. These findings identified crucial roles for
Pak1 in cardiomyocyte Ca2+ handling and demonstrated that it functions through
unique mechanisms involving regulation of the post-transcriptional activity of key
Ca2+-handling proteins, including the expression of Ca2+-ATPase SERCA2a, along
with the speculative possibility of an involvement in the maintenance of transverse
(T)-tubular structure. They highlight important regulatory functions of Pak1 in Ca2+
homeostasis in cardiac cells, and identify novel potential therapeutic strategies directed at
manipulation of Pak1 signaling for the management of cardiac disease, particularly heart
failure.
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Introduction
Protein kinases are versatile signaling molecules involved in the regulation of a wide range of
physiological processes. Of these, the p21-activated kinases (Paks) form a group of serine/threonine
protein kinases activated by Cdc42 and Rac1, and were first discovered in rat brain tissue two
decades ago (Manser et al., 1994). The structure, substrate-specificity and functional role of
Paks are evolutionarily conserved from protozoa to mammals. Vertebrate Paks are particularly
important in cytoskeletal remodeling and the assembly of focal adhesion structures, thereby
contributing to the modulation of dynamic processes such as cell migration and synaptic plasticity
(Manser and Lim, 1999; Hofmann et al., 2004; Zhao and Manser, 2005). Over the past decade,
significant progress has been made in understanding the functions of Pak1, a key member of the
Pak family, in particular, its roles in the regulation of excitability and contractility of the heart
(Ke et al., 2004, 2007, 2009). The present review now provides an updated account of these recent
findings regarding additional roles of Pak1 in Ca2+ homeostasis and Ca2+ handling in cardiac
cells.
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Regulation of L-Type Ca2+ Channels in
Sinoatrial Node Pacemaker Cells
The role of pak1 in the regulation of ion channel activity in car-
diomyocytes was first demonstrated in isolated guinea pig sinoa-
trial node (SAN) pacemaker cells (Ke et al., 2007). In cultured
guinea pig SAN cells, where active Pak1 expression was induced
through infection with recombinant adenovirus expressing con-
stitutively active Pak1 (CA-Pak1), responses of both L-type Ca2+
channel (LTCC) and delayed rectifier K+ channel currents to
β-adrenergic stimulation by isoproterenol were depressed in
comparison to SAN cells infected with control virus, Ad-LacZ.
Similarly chronotropic responses to isoproterenol stimulation,
reflected in repetitive action potential frequency were depressed
in both intact SAN tissue and isolated SAN cells expressing active
Pak1, when compared to controls expressing Ad-LacZ (Ke et al.,
2007). In contrast, Pak1 deletion in cardiac specific conditional
knockout (Pak1cko) or in total knockout mice resulted in an
increased SAN driven heart rate (Wang et al., 2014a). These
modified responses to isoproterenol stimulation in SAN tissue
and cells infected by CA-Pak1 likely reflect alterations in pro-
tein phosphorylation which modulate LTCC and delayed rec-
tifier K+ channel activity, and their responses to β-adrenergic
stimulation.
Our further studies focussing on LTCC regulation in SAN
cells implicated Pak1 as a regulator of protein phosphatase 2A
(PP2A). Immunoprecipitation studies indicated that Pak1 and
PP2A form a complex, leading to the hypothesis that Pak1 may
regulate LTCC activity through PP2A action (Ke et al., 2007).
This hypothesis was substantiated by studying the influence of
the PP2A inhibitor okadaic acid (OA) on the effects of isopro-
terenol on LTCC activity in Ad-Pak1–infected cells. OA partially
reversed the suppressant effect of active Pak1 on the response
of LTCCs to isoproterenol in Ad-Pak1–infected cells. This sug-
gests that Pak1 acts by increasing PP2A activity. Conversely,
our recent study demonstrated that mice with a cardiomyocyte-
specific Pak1 deletion (Pak1cko) showed higher heart rates than
their control littermates (Pak1f/f), although Pak1cko and con-
trol Pak1f/f mice showed similar baseline electrocardiographic
P wave durations and P-R, QRS and QT intervals (Wang et al.,
2014a).
Accumulating evidence implicates a coordinated interplay
between the activities of kinases and phosphatases in mod-
ulation of LTCC-mediated Ca2+ influx even in the absence
of humoral stimulation. For example, in the well-known β-
adrenergic receptor/protein kinase A (PKA) cascade, inhibitor-
1 is a downstream PKA target whose activation results in an
attenuation of protein phosphatase 1 (PP1) activity (Gupta et al.,
1996). Santana et al. (2002) showed that the phosphatase cal-
cineurin opposes PKA action in mouse ventricular myocytes.
Application of the PP2A inhibitor OA can activate LTCC (duBell
and Rogers, 2004). Calyculin A, which inhibits both PP1 and
PP2A, increases contractility in ventricular myocytes by increas-
ing LTCC activity (duBell et al., 2002). A complementary study
by duBell et al reported that addition of exogenous PP2A
decreased LTCC currents in rat ventricular myocytes (duBell
et al., 1996).
These results together suggested an existence of a dynamic
regulatory balance between kinase and phosphatase activity in
regulating the LTCC and delayed rectifier K+ channel activ-
ity in cardiac cells that may be important in controlling car-
diac pacemaker activity in response to autonomic and humoral
stimulation.
Regulation of Ca2+ Handling and Ca2+
Homeostasis in Ventricular Myocytes
In parallel with Pak1 action in SAN myocytes, enhanced Pak1
function brought about by Pak1 activating peptide, PAP (Wang
et al., 2014b) in ventricular tissue prevented hypertrophic asso-
ciated ventricular arrhythmias, and Pak1 deletion in Pak1cko or
in knockout mice increased the risks of ventricular alternans and
arrhythmias compared to WT mice. These findings went with a
co-immunoprecipitation of Pak1 and PP2A suggesting a com-
plex formation in ventricular myocytes, in common with SAN
cells (Ke et al., 2007). Recent studies have also suggested regula-
tory roles of Pak1 in Ca2+ homeostasis in ventricular myocytes
(Sheehan et al., 2009; DeSantiago et al., 2013; Wang et al.,
2014a). CA-Pak1 over-expression altered Ca2+ transient decay
constants (τCa) (Sheehan et al., 2009) and antagonized adrener-
gic signaling by attenuating isoproterenol-induced increases in
the activity ofLTCCs and other proteins regulating Ca2+ han-
dling (Sheehan et al., 2009). In contrast, ventricular myocytes
from Pak1cko mice with a cardiomyocyte-specific Pak1 knockout
showed abnormal Ca2+ homeostasis including increased dias-
tolic [Ca2+]i, as well as decreased sarcoplasmic reticular (SR)
Ca2+ content and decreased SERCA function, particularly during
β-adrenergic stress (Wang et al., 2014a). Significant differences in
Ca2+ homeostasis were observed between isolated Pak1cko and
wild type, Pak1f/f, ventricular myocytes. Diastolic [Ca2+]i was
higher in Pak1cko than Pak1f/f myocytes under both baseline
and chronic β-adrenergic stress conditions. Pak1cko myocytes
showed more frequent irregular, alternating Ca2+ transients
and/or Ca2+ waves at increased stimulation frequencies than
Pak1f/f myocytes under both baseline and chronic β-adrenergic
stress conditions during 0.5, 1, and 3Hz field stimulation. This
abnormal Ca2+ homeostasis in Pak1cko myocytes correlated with
differences in evoked cytosolic and SR Ca2+ responses between
Pak1f/f and Pak1cko myocytes, in both the absence and pres-
ence of chronic β-adrenergic stress (Wang et al., 2014a). Thus,
time constants for decays of the Na+-Ca2+ exchange (NCX) cur-
rent (INCX) following INCX induction by 10mM caffeine were
significantly greater in Pak1cko than Pak1f/f myocytes under
chronic β-adrenergic stress. SR Ca2+content, measured by inte-
gration of the INCX records, was reduced in Pak1
cko compared to
Pak1f/f myocytes in both the absence and presence of chronic β-
adrenergic stress. The decay rate constants of systolic Ca2+ tran-
sients in Pak1cko myocytes kSERCA, representing the kinetics of
cytosolic Ca2+ removal brought about by both SERCA and NCX,
was significantly lower than that shown by Pak1f/f myocytes in
both the absence and presence of chronic β-adrenergic stress
(Wang et al., 2014a). The rate constant kSERCA was reduced
by chronic β-adrenergic stress in both the Pak1f/f and Pak1cko
myocytes but more severely so in the Pak1cko myocytes. Finally,
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peak systolic [Ca2+]i, estimated from the differences between
peaks and baselines of systolic Ca2+ transients obtained during
regular stimulation, was indistinguishable between Pak1f/f and
Pak1cko under baseline conditions, but was significantly reduced
by chronic β-adrenergic stress in both Pak1f/f and Pak1cko, and
again more severely so in the Pak1cko (Wang et al., 2014a). In
contrast, LTCC activity was indistinguishable between Pak1cko
and Pak1f/f under both baseline and chronic β-adrenergic stress
conditions, but chronic β-adrenergic stress reduced LTCC cur-
rent in both Pak1cko and Pak1f/f ventricular myocytes, which
suggests that genetic deletion of Pak1 did not alter the expres-
sion and activity of LTCC in these cells. This result contrasts
with the effect of CA-Pak1 in SAN cells, and may reflect dif-
fering effects of Pak1 on ion channels in different cell types
or physiological conditions, and requires further investigation
(Wang et al., 2014a). These alterations in Ca2+ homeostasis were
associated with an increased incidence of ventricular arrhyth-
mias and electrophysiological instability during either acute
or chronic β-adrenergic challenge induced by isoproterenol in
Pak1cko hearts. Hencemodulation of Pak1 activitymodified Ca2+
handling under both physiological and β-adrenergic challenge
conditions.
Our further molecular studies associated these physiologi-
cal findings with an impaired SERCA2a function and down-
regulation of SERCA2amRNA and protein expression in Pak1cko
hearts (Wang et al., 2014a). Further exploration of this altered
transcriptional regulation in cultured neonatal rat cardiomy-
ocytes (NRCMs) demonstrated that exposure to control Ad-shC2
virus infection increased SERCA2a protein and mRNA levels
following phenylephrine challenge (Wang et al., 2014a). This
FIGURE 1 | Regulation of Ca2+ homeostasis by Pak1. Protein
kinase PKA and phosphatase PP2A are associated with key Ca2+
handling and regulatory proteins, which in turn are linked to upstream
signaling cascades. A balance of protein kinase and phosphatase
activities is required to maintain normal cardiac functions. Pak1 also
regulates hypertrophic signaling and gene expression of SERCA2a
through other signaling pathways by activating its downstream effectors
(e.g., JNK). (Liu et al., 2011; Wang et al., 2014a) (NCX: Na+-Ca2+
exchanger, PMCA: Plasma membrane Ca2+ ATPase, JNK: c-Jun
N-terminal Kinase).
was abolished by the Pak1-knockdown in Ad-shPak1-infected
NRCMs and increased by constitutive over-expression of active
Pak1 (Ad-CAPak1) (Wang et al., 2014a). This regulation
appeared to involve activation of serum response factor (SRF),
a transcriptional factor well-known for its vital role in regula-
tion of cardiogenesis genes in the Pak1-dependent regulation of
SERCA2a (Wang et al., 2014a).
The above results indicate that modulation of Pak1 activity
in ventricular myocytes can have a significant impact on Ca2+
handling in these cells under both baseline physiological and
β-adrenergic challenge conditions.
Possible Roles in Maintaining Transverse
(T)-Tubular Structure
Preliminary evidence (DeSantiago et al., 2013) suggests struc-
tural roles of Pak1, in addition to the above functional role
of Pak1 in maintaining transverse (T)-tubular structure, which
is altered in hypertrophic remodeling. Pak1−/− ventricular
myocytes showed decreased cell capacitances compared to WT
suggesting decreased T-tubular density. Under these condi-
tions, cells showed comparable SR Ca loads and phospholam-
ban phosphorylation, while their systolic Ca2+ transients showed
decreased amplitudes and delayed rise times, consistent with
a reduced coupling between LTCC-mediated Ca2+ influx and
RyR2-mediated Ca2+-induced Ca2+ release (CICR); changes
which were not observed in Pak1−/− atrial myocytes. Such find-
ings are consistent with the central role of T-tubules in triggering
and synchronizing excitation–contraction coupling, and merit
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further exploration. T-tubular remodeling has been reported in
other cardiac pathologies, and could well be involved in the
associated alterations in cellular processes, and hence cardiac
function.
In summary, as illustrated in Figure 1, these novel Pak1 effects
on Ca2+ homestasis complement previously established actions
upon PP2A and the resulting balance between kinase and phos-
phatase activity in controlling cardiac ion channel activity and
rhythmic Ca2+ cycling.
Earlier reports (Liu et al., 2011) had identified Pak1 as a novel
regulator of hypertrophic remodeling whose cardiomyocyte-
specific deletion exacerbated cardiac hypertrophy leading to
heart failure, following transverse aortic constriction. These fea-
tures were prevented by the non-selective Pak1 activator FTY720
in wild-type but not Pak1cko mice (Liu et al., 2013). Such car-
diac hypertrophy, with improved cardiac function and decreased
myocyte apoptosis compared to WT, was reduced in mice over-
expressing Pak1, with improved cardiac function and decreased
myocyte apoptosis compared to WT (Mao et al., 2009). A
recent study identified Pak1 as one of the significant genes
on the core networks for dilated cardiomyopathies by pathway
analyses in a Genome wide association study (GWAS) dataset
of patients suffering from DCM (Backes et al., 2014). Over
the past decade, significant progress has also been made in
understanding of additional roles of Pak1 in the regulation of
Ca2+ homeostasis and Ca2+ handling in turn regulating car-
diomyocyte excitability and contractility (Ke et al., 2004, 2007,
2009). There have also been speculative suggestions for a role
of Pak1 in the maintenance of transverse (T) tubule structure.
The present review now provides an updated account of these
recent findings. Thus, Pak1 may thus offer a novel therapeu-
tic target for modulation of Ca2+ handling in cardiac disease
conditions.
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